Joan Gavaldà i Santapau
Joan Gavaldà i Santapau
Infectious Diseases Senior Consultant. Infectious Diseases Department
Verified email at - Homepage
Cited by
Cited by
Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain1
JM Aguado, JA Herrero, J Gavaldá, J Torre-Cisneros, M Blanes, G Rufí, ...
Transplantation 63 (9), 1278-1286, 1997
Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study
J Gavalda, O Len, R San Juan, JM Aguado, J Fortun, C Lumbreras, ...
Clinical Infectious Diseases 41 (1), 52-59, 2005
Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort
J Torre-Cisneros, A Doblas, JM Aguado, R San Juan, M Blanes, ...
Clinical infectious diseases 48 (12), 1657-1665, 2009
Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for Treating Enterococcus faecalis Infective Endocarditis
N Fernández-Hidalgo, B Almirante, J Gavaldà, M Gurgui, C Peña, ...
Clinical infectious diseases 56 (9), 1261-1268, 2013
Bloodstream Infections Among Transplant Recipients: Results of a Nationwide Surveillance in Spain1
A Moreno, C Cervera, J Gavalda, M Rovira, R De La Cámara, I Jarque, ...
American Journal of Transplantation 7 (11), 2579-2586, 2007
Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone
J Gavalda, O Len, JM Miró, P Munoz, M Montejo, A Alarcón, ...
Annals of internal medicine 146 (8), 574-579, 2007
Invasive fungal infections in solid organ transplant recipients
J Gavaldà, Y Meije, J Fortún, E Roilides, F Saliba, O Lortholary, P Muñoz, ...
Clinical Microbiology and infection 20, 27-48, 2014
Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections
A Baelo, R Levato, E Julián, A Crespo, J Astola, J Gavaldà, E Engel, ...
Journal of Controlled Release 209, 150-158, 2015
Full face transplant: the first case report
JP Barret, J Gavaldà, J Bueno, X Nuvials, T Pont, N Masnou, ...
Annals of surgery 254 (2), 252-256, 2011
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors
V Monforte, A Roman, J Gavalda, C Bravo, L Tenorio, A Ferrer, J Maestre, ...
The Journal of heart and lung transplantation 20 (12), 1274-1281, 2001
Efficacy of Ampicillin plus Ceftriaxone in Treatment of Experimental Endocarditis Due to Enterococcus faecalis Strains Highly Resistant to Aminoglycosides
J Gavaldà, C Torres, C Tenorio, P López, M Zaragoza, JA Capdevila, ...
Antimicrobial agents and chemotherapy 43 (3), 639-646, 1999
Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation
R San Juan, JM Aguado, C Lumbreras, J Fortun, P Munoz, J Gavalda, ...
Clinical infectious diseases 47 (7), 875-882, 2008
Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group
R San Juan, JM Aguado, C Lumbreras, C Díaz‐Pedroche, ...
American journal of transplantation 7 (4), 964-971, 2007
Multidrug‐resistant bacteria in solid organ transplant recipients
C Cervera, C Van Delden, J Gavaldà, T Welte, M Akova, J Carratalà, ...
Clinical Microbiology and Infection 20, 49-73, 2014
Bacteremia Due to Campylobacter Species: Clinical Findings and Antimicrobial Susceptibility Patterns
C Pigrau, R Bartolome, B Almirante, AM Planes, J Gavalda, A Pahissa
Clinical infectious diseases 25 (6), 1414-1420, 1997
A 5-year prospective multicenter evaluation of influenza infection in transplant recipients
D Kumar, VH Ferreira, E Blumberg, F Silveira, E Cordero, ...
Clinical Infectious Diseases 67 (9), 1322-1329, 2018
Donor‐to‐host transmission of bacterial and fungal infections in lung transplantation
I Ruiz, J Gavaldà, V Monforte, O Len, A Román, C Bravo, A Ferrer, ...
American journal of transplantation 6 (1), 178-182, 2006
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients
J Torre-Cisneros, MC Fariñas, JJ Castón, JM Aguado, S Cantisán, ...
Enfermedades infecciosas y microbiologia clinica 29 (10), 735-758, 2011
Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients
J Fortún, P Martín-Dávila, M Montejo, P Muñoz, JM Cisneros, A Ramos, ...
Transplantation 87 (3), 424-435, 2009
Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety
V Monforte, P Ussetti, R López, J Gavaldà, C Bravo, A de Pablo, L Pou, ...
The Journal of heart and lung transplantation 28 (2), 170-175, 2009
The system can't perform the operation now. Try again later.
Articles 1–20